14 April 2026 Adcendo ApS Completes $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline read more
9 January 2026 Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets read more
7 January 2026 Poplar Therapeutics Launches With $50M Series A to Advance a New Class of Anti-IgE Therapy for Multiple Atopic Conditions read more
1 December 2025 Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance First-in-Class AL Amyloidosis Program into Pivotal Study read more
